Our results have shown significantly decreased levels of IL-13 in patients with steatosis, particularly those exhibiting advanced liver fibrosis, highlighting the importance of this pleiotropic cytokine in the pathogenesis of CHC as well. The gene discussed is IL13; the disease is Hepatic fibrosis.